← Eichor
Study identifier: NCT03624712 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms

Condition: Uterine Neoplasms  ·  Sponsor: University Hospital Tuebingen

PhaseN/A
Planned participants580
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Evaluation of clinical, therapeutic and prognostic relevance of new experimental results as well as optimization of therapeutic models and development of a new algorithm for therapeutic plan and therapy in patients with uterine neoplasm

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital Tuebingen, Department of Women's HealthTübingen, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03624712